Advanced Research on Vaccine Development for Infectious Diseases
A special issue of Pathogens (ISSN 2076-0817). This special issue belongs to the section "Vaccines and Therapeutic Developments".
Deadline for manuscript submissions: closed (31 October 2023) | Viewed by 1322
Special Issue Editors
Interests: animal virus; vaccines; transboundary diseases
Special Issue Information
Dear Colleagues,
Vaccination stands among the most decisive public health interventions in human history. Such an achievement is not only due to vaccines applied to the human population but also to those developed for animal health.
The most ancient records of prophylactic approaches for the immune prevention of infectious diseases are those related to the smallpox treatment in China and India between five and ten centuries ago. Following the same line, Jenner’s publications at the end of the 18th century, showing how experimental infections with cowpox may prevent or ameliorate further smallpox infections, could represent the onset of vaccinology as the science of vaccine development.
Different milestones stand out along this long journey from those rather rudimentary but pioneering approaches to modern vaccines: the development of bacterial culture techniques, the ability to produce in vitro viruses in tissue cultures, and new strategies applied from the molecular biology and advanced chemistry perspectives. As a result, an enormous array of vaccination strategies emerged, significantly improving the sanitary situation at a global scale within the One Health perspective.
This Special Issue will focus on original reports and reviews investigating the generation of novel vaccines against infectious agents and new approaches for evaluating vaccine-induced immune responses. Potential topics related to human and animal vaccinology include, but are not limited to, the following:
- Reverse genetics applied to vaccine development;
- New antigen delivery strategies, including vectored and nucleic acid-based vaccines, nanoparticles and immunostimulant complexes;
- New adjuvants and immunostimulatory strategies;
- Rationally designed live attenuated vaccines;
- Systems immunology applied to vaccine development and evaluation.
Dr. Mariano Pérez-Filgueira
Dr. Alejandra Capozzo
Guest Editors
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Pathogens is an international peer-reviewed open access monthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2700 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
Keywords
- recombinant vaccines
- production platforms
- protection
- antigen delivery
- adjuvants
